Clinical Trial: Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma (ELOQUENT - 1)
Sponsor and Collaborators
Bristol-Myers Squibb
Abbott Biotherapeutics
ClinicalTrials.gov Identifier
NCT01335399